medigraphic.com
ENGLISH

TIP Revista Especializada en Ciencias Químico-Biológicas

ISSN 2395-8723 (Digital)
ISSN 1405-888X (Impreso)
TIP Revista Especializada en Ciencias Químico-Biológicas
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2023, Número 1

<< Anterior Siguiente >>

TIP Rev Esp Cienc Quim Biol 2023; 26 (1)


Diversidad genética del Complejo de Mycobacterium tuberculosis: implicaciones clínicas y epidemiológicas

Gómez-Velasco A, Molina-Torres CA, Vera-Cabrera L, Bencomo-Alerm A, Muñoz-Jiménez SG, Sánchez-Pérez HJ, Gordillo-Marroquín C, Córdova-Solis CD, Enríquez-Ríos N, Nuñez ODB, Sánchez-Oropeza C, Nájera OJC, Rodríguez SRA
Texto completo Cómo citar este artículo Artículos similares

Idioma: Español
Referencias bibliográficas: 76
Paginas: 1-13
Archivo PDF: 243.35 Kb.


PALABRAS CLAVE

complejo de Mycobacterium tuberculosis, diversidad genética, diversidad fenotípica, evolución.

RESUMEN

El complejo de Mycobacterium tuberculosis (CMTB) es uno de los patógenos con mayor éxito evolutivo por su alta transmisión en las poblaciones humanas. En el 2022, la OMS estimó que aproximadamente 10.6 millones de personas desarrollaron la fase activa de la enfermedad, principalmente la forma pulmonar (tuberculosis pulmonar, TBP), y alrededor de 1.6 millones, más, fallecieron debido a la tuberculosis (TB). Diversas técnicas con base en el genotipo y la secuencia del genoma deThe genetic diversity of Mycobacterium tuberculosis: clinical and epidemiological outcomes. Mycobacterium tuberculosis (M. tb) han permitido entender su historia evolutiva y comprender las causas de su propagación mundial. El análisis y las comparaciones de la secuencia de los genomas completos indican que el CMTB se compone de nueve linajes, algunos están específicamente adaptados a los humanos y otros a los animales. La presencia de la mayoría de los linajes en África, hace de este continente el origen del CMTB. Los estudios del genoma del CMTB también han hecho posible la identificación de los genes implicados en su virulencia y patogenicidad, así como en el largo proceso co-evolutivo con su principal hospedero, el ser humano. En esta revisión se describe la diversidad genotípica y fenotípica del CMTB y sus implicaciones clínicas y epidemiológicas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Alexander, K. A., Larsen, M. H., Robbe-Austerman, S., Stuber,T. P. & Camp, P. M. (2016). Draft Genome Sequence ofthe Mycobacterium tuberculosis Complex Pathogen M.mungi, Identified in a Banded Mongoose (Mungos mungo)in Northern Botswana. Genome Announcements, 4(4).https://doi.org/10.1128/genomeA.00471-16

  2. Bach, H., Papavinasasundaram, K.G., Wong, D., Hmama, Z. &Av-Gay, Y. (2008). Mycobacterium tuberculosis virulenceis mediated by PtpA dephosphorylation of human vacuolarprotein sorting 33B. Cell Host & Microbe, 3(5), 316-322.https://doi.org/10.1016/j.chom.2008.03.008

  3. Baker, L., Brown, T., Maiden, M. C. & Drobniewski, F. (2004).Silent nucleotide polymorphisms and a phylogeny forMycobacterium tuberculosis. Emerging Infectious Diseases,10(9), 1568-1577.

  4. Barberis, I., Bragazzi, N. L., Galluzzo, L. & Martini, M. (2017).The history of tuberculosis: From the first historical recordsto the isolation of Koch’s bacillus. Journal of PreventiveMedicine and Hygiene, 58(1), E9-E12.

  5. Barksdale, L. & Kim, K. S. (1977). Mycobacterium.Bacteriological Reviews, 41(1), 217-372.

  6. Bottai, D., Frigui, W., Sayes, F., Di Luca, M., Spadoni, D.,Pawlik, A., Zoppo, M., Orgeur, M., Khanna, V., Hardy, D.,Mangenot, S., Barbe, V., Medigue, C., Ma, L., Bouchier,C., Tavanti, A., Larrouy-Maumus, G. & Brosch, R.(2020). TbD1 deletion as a driver of the evolutionarysuccess of modern epidemic Mycobacterium tuberculosislineages. Nature Communications, 11(1), 684. https://doi.org/10.1038/s41467-020-14508-5

  7. Bottai, D., Stinear, T. P., Supply, P. & Brosch, R. (2014).Mycobacterial Pathogenomics and Evolution. MicrobiologySpectrum, 2(1), MGM2-0025-2013. https://doi.org/10.1128/microbiolspec.MGM2-0025-2013

  8. Brites, D., Loiseau, C., Menardo, F., Borrell, S., Boniotti, M.B., Warren, R., Dippenaar, A., Parsons, S. D. C., Beisel,C., Behr, M. A., Fyfe, J. A., Coscolla, M. & Gagneux,S. (2018). A New Phylogenetic Framework for theAnimal-Adapted Mycobacterium tuberculosis Complex.Frontiers in Microbiology, 9, 1-9. https://doi.org/10.3389/fmicb.2018.02820

  9. Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P., Buchrieser,C., Eiglmeier, K., Garnier, T., Gutierrez, C., Hewinson,G., Kremer, K., Parsons, L. M., Pym, A. S., Samper, S.,Soolingen, D. & Cole, S. T. (2002). A new evolutionaryscenario for the Mycobacterium tuberculosis complex.Proceedings of the National Academy of Sciences, 99(6),3684-3689. https://doi.org/10.1073/pnas.052548299

  10. Brown, T. S., Challagundla, L., Baugh, E. H., Omar, S. V.,Mustaev, A., Auld, S. C., Shah, N. S., Kreiswirth, B. N.,Brust, J. C. M., Nelson, K. N., Narechania, A., Kurepina,N., Mlisana, K., Bonneau, R., Eldholm, V., Ismail, N.,Kolokotronis, S.-O., Robinson, D. A., Gandhi, N. R. &Mathema, B. (2019). Pre-detection history of extensivelydrug-resistant tuberculosis in KwaZulu-Natal, South Africa.Proceedings of the National Academy of Sciences, 116(46),23284-23291. https://doi.org/10.1073/pnas.1906636116

  11. Brynildsrud, O. B., Pepperell, C. S., Suffys, P., Grandjean,L., Monteserin, J., Debech, N., Bohlin, J., Alfsnes, K.,Pettersson, J. O.-H., Kirkeleite, I., Fandinho, F., da Silva,M. A., Perdigao, J., Portugal, I., Viveiros, M., Clark, T.,Caws, M., Dunstan, S., Thai, P. V. K., Lopez, B., Ritacco,V., Kitchen, A., Brown, T. S., van Soolingen, D., O’Neill,M. B., Holt, K. E., Feil, E. J., Mathema, B., Balloux, F. &Eldholm, V. (2018). Global expansion of Mycobacteriumtuberculosis lineage 4 shaped by colonial migration andlocal adaptation. Science Advances, 4(10), eaat5869. https://doi.org/10.1126/sciadv.aat5869

  12. Cadena, A. M., Fortune, S. M. & Flynn, J. L. (2017).Heterogeneity in tuberculosis. Nature Reviews. Immunology,17(11), 691-702. https://doi.org/10.1038/nri.2017.69

  13. Casali, N. & Riley, L. W. (2007). A phylogenomic analysis ofthe Actinomycetales mce operons. BMC Genomics, 8(1),60. https://doi.org/10.1186/1471-2164-8-60

  14. Cohen, K. A., Abeel, T., McGuire, A. M., Desjardins, C. A.,Munsamy, V., Shea, T. P., Walker, B. J., Bantubani, N.,Almeida, D.V., Alvarado, L., Chapman, S. B., Mvelase,N. R., Duffy, E. Y., Fitzgerald, M. G., Govender, P., Gujja,S., Hamilton, S., Howarth, C., Larimer, J. D., Earl, A.M., Maharaj, K., Pearson, M. D., Priest, M. E., Zeng, Q.,Padayatchi, N., Grosset, J., Young, S. K., Wortman, J.,Mlisana, K. P., O’Donnell, M. R., Birren, B. W., Bishai,W. R., Pym, A. S. & Earl, A. M. (2015). Evolution ofExtensively Drug-Resistant Tuberculosis over FourDecades: Whole Genome Sequencing and Dating Analysisof Mycobacterium tuberculosis Isolates from KwaZulu-Natal. PLOS Medicine, 12(9), e1001880. https://doi.org/10.1371/journal.pmed.1001880

  15. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C.,Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry,C. E., Tekaia, F., Badcock, K., Bashman, D., Brown, D.,Chillingworth, T., Connor, R., Davies, R., Devlin, K.,Feltwell, T., Gentles, S., Hamlin, N., Holroyd, S., Hornsby,T., Jagels, K., Krogh, A., McLean, J., Moule, S., Murphy,L., Oliver, K., Osborne, J., Quail, M., A., Rajandream, M.,A., Rogers, J., Rutter, S., Seeger, K., Skelton, J., Squares,R., Squares, S., Sulston, J., E., Taylor, K., Whitehead,S. & Barrell, B. G. (1998). Deciphering the biology ofMycobacterium tuberculosis from the complete genomesequence. Nature, 393(6685), 537-544. https://doi.org/10.1038/31159

  16. Comas, I., Coscolla, M., Luo, T., Borrell, S., Holt, K. E., Kato-Maeda, M., Parkhill, J., Malla, B., Berg, S., Thwaites, G.,Yeboah-Manu, D., Bothamley, G., Mei, J., Wei, L., Bentley,S., Harris, S. R., Niemann, S., Diel, R., Aseffa, A., Gao, Q.,Young, D. & Gagneux, S. (2013). Out-of-Africa migrationand Neolithic coexpansion of Mycobacterium tuberculosiswith modern humans. Nature Genetics, 45(10), 1176-1182.https://doi.org/10.1038/ng.2744

  17. Coscolla, M. (2017). Biological and EpidemiologicalConsequences of MTBC Diversity. En S. Gagneux (Ed.),Strain Variation in the Mycobacterium tuberculosisComplex: Its Role in Biology, Epidemiology and Control(pp. 95-116). Springer International Publishing. https://doi.org/10.1007/978-3-319-64371-7_5

  18. Coscolla, M. & Gagneux, S. (2010). Does M. tuberculosisgenomic diversity explain disease diversity? Drug DiscoveryToday. Disease Mechanisms, 7(1), e43-e59. https://doi.org/10.1016/j.ddmec.2010.09.004

  19. Coscolla, M., Gagneux, S., Menardo, F., Loiseau, C., Ruiz-Rodriguez, P., Borrell, S., Otchere, I. D., Asante-Poku, A.,Asare, P., Sánchez-Busó, L., Gehre, F., Sanoussi, C. N.,Antonio, M., Affolabi, D., Fyfe, J., Beckert, P., Niemann,S., Alabi, A. S., Grobusch, M. P., Kobbe, R., Parkhill, J.,Beisel, C., Fenner, L., Böttger, E. C., Meehan, C. J., Harris,S. R., de Jong, B. C., Yeboah-Manu, D. & Brites, D. (2021).Phylogenomics of Mycobacterium africanum reveals anew lineage and a complex evolutionary history. MicrobialGenomics, 7(2). https://doi.org/10.1099/mgen.0.000477

  20. Coscolla, M., Lewin, A., Metzger, S., Maetz-Rennsing, K.,Calvignac-Spencer, S., Nitsche, A., Dabrowski, P. W.,Radonic, A., Niemann, S., Parkhill, J., Couacy-Hymann,E., Feldman, J., Comas, I., Boesch, C., Gagneux, S. &Leendertz, F. H. (2013). Novel Mycobacterium tuberculosiscomplex isolate from a wild chimpanzee. EmergingInfectious Diseases, 19(6), 969-976. https://doi.org/10.3201/eid1906.121012

  21. Cousins, D. V., Bastida, R., Cataldi, A., Quse, V., Redrobe, S.,Dow, S., Duignan, P., Murray, A., Dupont, C., Ahmed, N.,Collins, D. M., Butler, W. R., Dawson, D., Rodríguez, D.,Loureiro, J., Romano, M. I., Alito, A., Zumarraga, M. &Bernardelli, A. (2003). Tuberculosis in seals caused by anovel member of the Mycobacterium tuberculosis complex:Mycobacterium pinnipedii sp. nov. International Journalof Systematic and Evolutionary Microbiology, 53(Pt 5),1305-1314. https://doi.org/10.1099/ijs.0.02401-0

  22. de Jong, B. C., Hill, P. C., Aiken, A., Awine, T., Antonio, M.,Adetifa, I. M., Jackson-Sillah, D. J., Fox, A., Deriemer, K.,Gagneux, S., Borgdorff, M. W., McAdam, K. P. W. J., Corrah,T., Small, P. M. & Adegbola, R. A. (2008). Progressionto active tuberculosis, but not transmission, varies byMycobacterium tuberculosis lineage in The Gambia. TheJournal of Infectious Diseases, 198(7),1037-1043. https://doi.org/10.1086/591504

  23. Demay, C., Liens, B., Burguière, T., Hill, V., Couvin, D.,Millet, J., Mokrousov, I., Sola, C., Zozio, T. & Rastogi, N.(2012). SITVITWEB--a publicly available internationalmultimarker database for studying Mycobacteriumtuberculosis genetic diversity and molecular epidemiology.Infection, Genetics and Evolution: Journal of MolecularEpidemiology and Evolutionary Genetics in InfectiousDiseases, 12(4), 755-766. https://doi.org/10.1016/j.meegid.2012.02.004

  24. Dippenaar, A., Parsons, S. D. C., Sampson, S. L., van derMerwe, R. G., Drewe, J. A., Abdallah, A. M., Siame, K.K., Gey van Pittius, N. C., van Helden, P. D., Pain, A. &Warren, R. M. (2015). Whole genome sequence analysis ofMycobacterium suricattae. Tuberculosis, 95(6), 682-688.https://doi.org/10.1016/j.tube.2015.10.001

  25. Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo,K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn,D. M. & Sherman, D. R. (2018). Incipient and SubclinicalTuberculosis: A Clinical Review of Early Stages andProgression of Infection. Clinical Microbiology Reviews,31(4), e00021-18 https://doi.org/10.1128/CMR.00021-18

  26. Ebrahimi-Rad, M., Bifani, P., Martin, C., Kremer, K., Samper,S., Rauzier, J., Kreiswirth, B., Blazquez, J., Jouan, M., vanSoolingen, D. & Gicquel, B. (2003). Mutations in putativemutator genes of Mycobacterium tuberculosis strains ofthe W-Beijing family. Emerging Infectious Diseases, 9(7),838-845. https://doi.org/10.3201/eid0907.020803

  27. Firdessa, R., Berg, S., Hailu, E., Schelling, E., Gumi, B.,Erenso, G., Gadisa, E., Kiros, T., Habtamu, M., Hussein,J., Zinsstag, J., Robertson, B. D., Ameni, G., Lohan, A. J.,Loftus, B., Comas, I., Gagneux, S., Tschopp, R., Yamuah,L., Hewinson, G., Gordon, S. V., Young, D. B. & Aseffa,A. (2013). Mycobacterial lineages causing pulmonaryand extrapulmonary tuberculosis, Ethiopia. EmergingInfectious Diseases, 19(3), 460-463. https://doi.org/10.3201/eid1903.120256

  28. Fu, L. M. & Fu-Liu, C. S. (2002). Is Mycobacterium tuberculosisa closer relative to Gram-positive or Gram-negative bacterialpathogens? Tuberculosis (Edinburgh, Scotland), 82(2-3),85-90. https://doi.org/10.1054/tube.2002.0328

  29. Gagneux, S. (2012). Host-pathogen coevolution in humantuberculosis. Philosophical transactions of the Royal Societyof London. Series B, Biological sciences, 367(1590), 850-859. https://doi.org/10.1098/rstb.2011.0316

  30. Gagneux, S. (2018). Ecology and evolution of Mycobacteriumtuberculosis. Nature Reviews Microbiology, 16(4), 202-213.https://doi.org/10.1038/nrmicro.2018.8

  31. Gagneux, S., DeRiemer, K., Van, T., Kato-Maeda, M., Jong,B. C. de, Narayanan, S., Nicol, M., Niemann, S., Kremer,K., Gutierrez, M. C., Hilty, M., Hopewell, P. C. & Small,P. M. (2006). Variable host–pathogen compatibility inMycobacterium tuberculosis. Proceedings of the NationalAcademy of Sciences of the United States of America, 103(8),2869-2873. https://doi.org/10.1073/pnas.0511240103

  32. Galagan, J. E. (2014). Genomic insights into tuberculosis.Nature Reviews Genetics, 15(5), 307-320. https://doi.org/10.1038/nrg3664

  33. Gandhi, N. R., Nunn, P., Dheda, K., Schaaf, H. S., Zignol, M., vanSoolingen, D., Jensen, P. & Bayona, J. (2010). Multidrugresistantand extensively drug-resistant tuberculosis: A threatto global control of tuberculosis. Lancet, 375(9728), 1830-1843. https://doi.org/10.1016/S0140-6736(10)60410-2

  34. Garnier, T., Eiglmeier, K., Camus, J.-C., Medina, N., Mansoor, H.,Pryor, M., Duthoy, S., Grondin, S., Lacroix, C., Monsempe,C., Simon, S., Harris, B., Atkin, R., Doggett, J., Mayes, R.,Keating, L., Wheeler, P. R., Parkhill, J., Barrell, B. G., ColeS.T., Gordon, S.,V. & Hewinson, R.,G. (2003). The completegenome sequence of Mycobacterium bovis. Proceedingsof the National Academy of Sciences of the United Statesof America, 100(13), 7877-7882. https://doi.org/10.1073/pnas.1130426100

  35. Glynn, J. R., Whiteley, J., Bifani, P. J., Kremer, K. & vanSoolingen, D. (2002). Worldwide occurrence of Beijing/Wstrains of Mycobacterium tuberculosis: A systematic review.Emerging Infectious Diseases, 8(8), 843-849. https://doi.org/10.3201/eid0805.020002

  36. Gupta, R. S., Lo, B. & Son, J. (2018). Phylogenomics andComparative Genomic Studies Robustly Support Divisionof the Genus Mycobacterium into an Emended GenusMycobacterium and Four Novel Genera. Frontiers inMicrobiology, 9(67), 1-11. https://doi.org/10.3389/fmicb.2018.00067

  37. Gutierrez, M. C., Brisse, S., Brosch, R., Fabre, M., Omaïs,B., Marmiesse, M., Supply, P. & Vincent, V. (2005).Ancient origin and gene mosaicism of the progenitor ofMycobacterium tuberculosis. PLoS Pathogens, 1(1), e5.https://doi.org/10.1371/journal.ppat.0010005

  38. Hershberg, R., Lipatov, M., Small, P. M., Sheffer, H., Niemann,S., Homolka, S., Roach, J. C., Kremer, K., Petrov, D. A.,Feldman, M. W. & Gagneux, S. (2008). High functionaldiversity in Mycobacterium tuberculosis driven by geneticdrift and human demography. PLoS Biology, 6(12), e311.https://doi.org/10.1371/journal.pbio.0060311

  39. Hershkovitz, I., Donoghue, H. D., Minnikin, D. E., May, H.,Lee, O.Y.-C., Feldman, M., Galili, E., Spigelman, M.,Rothschild, B. M. & Bar-Gal, G. K. (2015). Tuberculosisorigin: The Neolithic scenario. Tuberculosis, 95(Suppl1), S122-S126. https://doi.org/10.1016/j.tube.2015.02.021

  40. Ioerger, T. R., Koo, S., No, E.-G., Chen, X., Larsen, M. H.,Jr, W. R. J., Pillay, M., Sturm, A. W. & Sacchettini, J. C.(2009). Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South Africa.PLOS ONE, 4(11), e7778. https://doi.org/10.1371/journal.pone.0007778

  41. Kamerbeek, J., Schouls, L., Kolk, A., van Agterveld, M., vanSoolingen, D., Kuijper, S., Bunschoten, A., Molhuizen, H.,Shaw, R., Goyal, M. & van Embden, J. (1997). Simultaneousdetection and strain differentiation of Mycobacteriumtuberculosis for diagnosis and epidemiology. Journal ofClinical Microbiology, 35(4), 907-914.

  42. Koeck, J.-L., Fabre, M., Simon, F., Daffé, M., Garnotel, E.,Matan, A. B., Gérôme, P., Bernatas, J.-J., Buisson, Y. &Pourcel, C. (2011). Clinical characteristics of the smoothtubercle bacilli Mycobacterium canettii infection suggestthe existence of an environmental reservoir. ClinicalMicrobiology and Infection: The Official Publication of theEuropean Society of Clinical Microbiology and InfectiousDiseases, 17(7), 1013-1019. https://doi.org/10.1111/j.1469-0691.2010.03347.x

  43. Kubica, G. P., Kim, T. & Dunbar, F. (1972). Designation ofstrain H37Rv as the neotype of Mycobacterium tuberculosis.International Journal of Systematic Bacteriology, 22(2),99-106.

  44. Loiseau, C., Menardo, F., Aseffa, A., Hailu, E., Gumi, B.,Ameni, G., Berg, S., Rigouts, L., Robbe-Austerman, S.,Zinsstag, J., Gagneux, S. & Brites, D. (2020). An Africanorigin for Mycobacterium bovis. Evolution, Medicine, andPublic Health, 2020(1), 49-59. https://doi.org/10.1093/emph/eoaa005

  45. López, B., Aguilar, D., Orozco, H., Burger, M., Espitia, C.,Ritacco, V., Barrera, L., Kremer, K., Hernandez-Pando,R., Huygen, K. & van Soolingen, D. (2003). A markeddifference in pathogenesis and immune response induced bydifferent Mycobacterium tuberculosis genotypes. Clinicaland Experimental Immunology, 133(1), 30-37. https://doi.org/10.1046/j.1365-2249.2003.02171.x

  46. Ma, R., Farrell, D., Gonzalez, G., Browne, J. A., Nakajima, C.,Suzuki, Y. & Gordon, S. V. (2022). The TbD1 Locus Mediatesa Hypoxia-Induced Copper Response in Mycobacteriumbovis. Frontiers in Microbiology, 14(13):817952. https://www.frontiersin.org/articles/10.3389/fmicb.2022.817952

  47. Merker, M., Blin, C., Mona, S., Duforet-Frebourg, N., Lecher,S., Willery, E., Blum, M. G. B., Rüsch-Gerdes, S.,Mokrousov, I., Aleksic, E., Allix-Béguec, C., Antierens,A., Augustynowicz-Kopeć, E., Ballif, M., Barletta, F.,Beck, H. P., Barry, C. E., Bonnet, M., Borroni, E., Campos-Herrero, I., Cirillo, D., Cox, H., Crowe, S., Crudu, V., Diel,R., Drobniewski, F., Fauville-Dufaux, M., Gagneux, S.,Ghebremichael, S., Hanekom, M., Hoffner, S., Jiao, W.W., Kalon, S., Kohl, T. A., Kontsevaya, I., Lillebæk, T.,Maeda, S., Nikolayevskyy, V., Rasmussen, M., Rastogi,N., Samper, S., Sanchez-Padilla, E., Savic, B., Shamputa, I.C., Shen, A., Sng, L. H., Stakenas, P., Toit, K., Varaine, F.,Vukovic, D., Wahl, C., Warren, R., Supply, P., Niemann, S.& Wirth, T. (2015). Evolutionary history and global spreadof the Mycobacterium tuberculosis Beijing lineage. NatureGenetics, 47(3), 242-249. https://doi.org/10.1038/ng.3195

  48. Minnikin, D. E., Lee, O.Y.-C., Wu, H. H. T., Besra, G. S.,Bhatt, A., Nataraj, V., Rothschild, B. M., Spigelman, M.& Donoghue, H. D. (2015). Ancient mycobacterial lipids:Key reference biomarkers in charting the evolution oftuberculosis. Tuberculosis (Edinburgh, Scotland), 95(Suppl1), S133-139. https://doi.org/10.1016/j.tube.2015.02.009

  49. Mtei, L., Matee, M., Herfort, O., Bakari, M., Horsburgh, C.R., Waddell, R., Cole, B. F., Vuola, J. M., Tvaroha, S.,Kreiswirth, B., Pallangyo, K. & von Reyn, C. F. (2005).High rates of clinical and subclinical tuberculosis amongHIV-infected ambulatory subjects in Tanzania. ClinicalInfectious Diseases: An Official Publication of the InfectiousDiseases Society of America, 40(10), 1500-1507. https://doi.org/10.1086/429825

  50. Naidoo, K., Moodley, M. C., Hassan-Moosa, R., Dookie, N.,Yende-Zuma, N., Perumal, R., Dawood, H., Mvelase, N. R.,Mathema, B. & Karim, S. A. (2022). Recurrent SubclinicalTuberculosis Among Antiretroviral Therapy-AccessingParticipants: Incidence, Clinical Course, and Outcomes.Clinical Infectious Diseases: An Official Publication of theInfectious Diseases Society of America, 75(9), 1628-1636.https://doi.org/10.1093/cid/ciac185

  51. Ngabonziza, J. C. S., Loiseau, C., Marceau, M., Jouet, A.,Menardo, F., Tzfadia, O., Antoine, R., Niyigena, E. B.,Mulders, W., Fissette, K., Diels, M., Gaudin, C., Duthoy,S., Ssengooba, W., André, E., Kaswa, M. K., Habimana, Y.M., Brites, D., Affolabi, D., Mazarati, J., B., de Jong, B., C.,Rigouts, L., Gagneux, S., Meehan, C. J. & Supply, P. (2020).A sister lineage of the Mycobacterium tuberculosis complexdiscovered in the African Great Lakes region. NatureCommunications, 11(1), 2917. https://doi.org/10.1038/s41467-020-16626-6

  52. Oni, T., Burke, R., Tsekela, R., Bangani, N., Seldon, R., Gideon,H. P., Wood, K., Wilkinson, K. A., Ottenhoff, T. H. M. &Wilkinson, R. J. (2011). High prevalence of subclinicaltuberculosis in HIV-1-infected persons without advancedimmunodeficiency: Implications for TB screening. Thorax,66(8), 669-673. https://doi.org/10.1136/thx.2011.160168

  53. Otal, I., Martín, C., Vincent-Lévy-Frebault, V., Thierry,D. & Gicquel, B. (1991). Restriction fragment lengthpolymorphism analysis using IS6110 as an epidemiologicalmarker in tuberculosis. Journal of Clinical Microbiology,29(6), 1252-1254. https:// doi: 10.1128/jcm.29.6.1252-1254.1991

  54. Pandey, A. K. & Sassetti, C. M. (2008). Mycobacterial persistencerequires the utilization of host cholesterol. Proceedingsof the National Academy of Sciences of the United Statesof America, 105(11), 4376-4380. https://doi.org/10.1073/pnas.0711159105

  55. Parwati, I., van Crevel, R. & van Soolingen, D. (2010). Possibleunderlying mechanisms for successful emergence of theMycobacterium tuberculosis Beijing genotype strains. TheLancet Infectious Diseases, 10(2), 103-111. https://doi.org/10.1016/S1473-3099(09)70330-5

  56. Prodinger, W. M., Indra, A., Koksalan, O. K., Kilicaslan, Z.& Richter, E. (2014). Mycobacterium caprae infection inhumans. Expert Review of Anti-Infective Therapy, 12(12),1501-1513. https://doi.org/10.1586/14787210.2014.974560

  57. Quigley, J., Hughitt, V. K., Velikovsky, C. A., Mariuzza, R. A.,El-Sayed, N. M. & Briken, V. (2017). The Cell Wall LipidPDIM Contributes to Phagosomal Escape and Host CellExit of Mycobacterium tuberculosis. MBio, 8(2). https://doi.org/10.1128/mBio.00148-17

  58. Riojas, M. A., McGough, K. J., Rider-Riojas, C. J., Rastogi, N. &Hazbón, M. H. (2018). Phylogenomic analysis of the speciesof the Mycobacterium tuberculosis complex demonstratesthat Mycobacterium africanum, Mycobacterium bovis,Mycobacterium caprae, Mycobacterium microti andMycobacterium pinnipedii are later heterotypic synonymsof Mycobacterium tuberculosis. International Journal ofSystematic and Evolutionary Microbiology, 68(1), 324-332.https://doi.org/10.1099/ijsem.0.002507

  59. Shah, N. S., Auld, S. C., Brust, J. C. M., Mathema, B., Ismail,N., Moodley, P., Mlisana, K., Allana, S., Campbell, A.,Mthiyane, T., Morris, N., Mpangase, P., van der Meulen,H., Omar, S. V., Brown, T. S., Narechania, A., Shaskina,E., Kapwata, T., Kreiswirth, B. & Gandhi, N. R. (2017).Transmission of Extensively Drug-Resistant Tuberculosisin South Africa. The New England Journal of Medicine,376(3), 243-253. https://doi.org/10.1056/NEJMoa1604544

  60. Silva-Pereira, T. T., Ikuta, C. Y., Zimpel, C. K., Camargo, N. C.S., de Souza Filho, A. F., Ferreira Neto, J. S., Heinemann,M. B. & Guimarães, A.M.S. (2019). Genome sequencing ofMycobacterium pinnipedii strains: Genetic characterizationand evidence of superinfection in a South American sea lion(Otaria flavescens). BMC Genomics, 20(1), 1030. https://doi.org/10.1186/s12864-019-6407-5

  61. Smith, N. H., Crawshaw, T., Parry, J. & Birtles, R. J. (2009).Mycobacterium microti: More diverse than previouslythought. Journal of Clinical Microbiology, 47(8), 2551-2559. https://doi.org/10.1128/JCM.00638-09

  62. Stringer, C. (2016). The origin and evolution of Homo sapiens.Philos Trans R Soc. Lond B Biol. Sci., 371(1698):20150237.https://doi.org/10.1098/rstb.2015.0237

  63. Stucki, D., Brites, D., Jeljeli, L., Coscolla, M., Liu, Q., Trauner,A., Fenner, L., Rutaihwa, L., Borrell, S., Luo, T., Gao,Q., Kato-Maeda, M., Ballif, M., Egger, M., Macedo, R.,Mardassi, H., Moreno, M., Tudo Vilanova, G., Fyfe, J.,Globan, M., Thomas, J., Jamieson, F., Guthrie, J. L., Asante-Poku, A., Yeboah-Manu, D., Wampande, E., Ssengooba, W.,Joloba, M., Henry Boom, W., Basu, I., Bower, J., Saraiva,M., Vaconcellos, S. E. G., Suffys, P., Koch, A., Wilkinson,R., Gail-Bekker, L., Malla, B., Ley, S. D., Beck, H. P., deJong, B. C., Toit, K., Sanchez-Padilla, E., Bonnet, M.,Gil-Brusola, A., Frank, M., Penlap Beng, V. N., Eisenach,K., Alani, I., Wangui Ndung’u, P., Revathi, G., Gehre, F.,Akter, S., Ntoumi, F., Stewart-Isherwood, L., Ntinginya,N. E., Rachow, A., Hoelscher, M., Cirillo, D. M., Skenders,G., Hoffner, S., Bakonyte, D., Stakenas, P., Diel, R., Crudu,V., Moldovan, O., Al-Hajoj, S., Otero, L., Barletta, F., JaneCarter, E., Diero, L., Supply, P., Comas, I., Niemann, S. &Gagneux, S. (2016). Mycobacterium tuberculosis lineage 4comprises globally distributed and geographically restrictedsublineages. Nature Genetics, 48(12), 1535-1543. https://doi.org/10.1038/ng.3704

  64. Supply, P., Allix, C., Lesjean, S., Cardoso-Oelemann, M.,Rüsch-Gerdes, S., Willery, E., Savine, E., de Haas, P.,van Deutekom, H., Roring, S., Bifani, P., Kurepina, N.,Kreiswirth, B., Sola, C., Rastogi, N., Vatin, V., Gutierrez, M.C., Fauville, M., Niemann, S., Skuc, R., Kremer, K, Locht,C. & van Soolingen, D. (2006). Proposal for standardizationof optimized mycobacterial interspersed repetitive unitvariable-number tandem repeat typing of Mycobacteriumtuberculosis. Journal of Clinical Microbiology, 44(12),4498-4510. https://doi.org/10.1128/JCM.01392-06

  65. Swaminathan, S., Paramasivan, C. N., Kumar, S. R., Mohan,V. & Venkatesan, P. (2004). Unrecognised tuberculosis inHIV-infected patients: Sputum culture is a useful tool. TheInternational Journal of Tuberculosis and Lung Disease,8(7), 896-898.

  66. Tientcheu, L. D., Koch, A., Ndengane, M., Andoseh, G.,Kampmann, B. & Wilkinson, R. J. (2017). Immunologicalconsequences of strain variation within the Mycobacteriumtuberculosis complex. European Journal of Immunology,47(3), 432-445. https://doi.org/10.1002/eji.201646562

  67. Tientcheu, L. D., Sutherland, J. S., de Jong, B. C., Kampmann,B., Jafali, J., Adetifa, I. M., Antonio, M., Dockrell, H. M. &Ota, M. O. (2014). Differences in T-cell responses betweenMycobacterium tuberculosis and Mycobacterium africanuminfectedpatients. European Journal of Immunology, 44(5),1387-1398. https://doi.org/10.1002/eji.201343956

  68. Tió-Coma, M., Wijnands, T., Pierneef, L., Schilling, A. K.,Alam, K., Roy, J. C., Faber, W. R., Menke, H., Pieters,T., Stevenson, K., Richardus, J. H. & Geluk, A. (2019).Detection of Mycobacterium leprae DNA in soil: Multipleneedles in the haystack. Scientific Reports, 9(1), 3165.https://doi.org/10.1038/s41598-019-39746-6

  69. van Ingen, J., Rahim, Z., Mulder, A., Boeree, M. J., Simeone,R., Brosch, R. & van Soolingen, D. (2012). Characterizationof Mycobacterium orygis as M. tuberculosis complexsubspecies. Emerging Infectious Diseases, 18(4), 653-655.https://doi.org/10.3201/eid1804.110888

  70. VanderVen, B. C., Huang, L., Rohde, K. H. & Russell, D. G.(2016). The Minimal Unit of Infection: Mycobacteriumtuberculosis in the Macrophage. Microbiology Spectrum,4(6). https://doi.org/10.1128/microbiolspec.TBTB2-0025-2016

  71. Via, L. E., Weiner, D. M., Schimel, D., Lin, P. L., Dayao, E.,Tankersley, S. L., Cai, Y., Coleman, M. T., Tomko, J.,Paripati, P., Orandle, M., Kastenmayer, R. J., Tartakovsky,M., Rosenthal, A., Portevin, D., Eum, S. Y., Lahouar, S.,Gagneux, S., Young, D. B., Flynn, J., L. & Barry, C., E.(2013). Differential virulence and disease progressionfollowing Mycobacterium tuberculosis complex infectionof the common marmoset (Callithrix jacchus). Infectionand Immunity, 81(8), 2909-2919. https://doi.org/10.1128/IAI.00632-13

  72. WHO. (2022). Global Tuberculosis Report 2022. WHO. https://www.who.int/publications/i/item/9789240037021

  73. Wong, D., Bach, H., Sun, J., Hmama, Z. & Av-Gay, Y.(2011). Mycobacterium tuberculosis protein tyrosinephosphatase (PtpA) excludes host vacuolar-H+-ATPaseto inhibit phagosome acidification. Proceedings of theNational Academy of Sciences of the United States ofAmerica, 108(48), 19371-19376. https://doi.org/10.1073/pnas.1109201108

  74. Yam, K. C., D’Angelo, I., Kalscheuer, R., Zhu, H., Wang, J.-X., Snieckus, V., Ly, L. H., Converse, P. J., Jacobs, W. R.,Strynadka, N. & Eltis, L. D. (2009). Studies of a ring-cleavingdioxygenase illuminate the role of cholesterol metabolismin the pathogenesis of Mycobacterium tuberculosis. PLoSPathogens, 5(3), e1000344. https://doi.org/10.1371/journal.ppat.1000344

  75. Yeboah-Manu, D., de Jong, B. C. & Gehre, F. (2017). TheBiology and Epidemiology of Mycobacterium africanum.Advances in Experimental Medicine and Biology, 1019,117-133. https://doi.org/10.1007/978-3-319-64371-7_6

  76. Yimer, S. A., Norheim, G., Namouchi, A., Zegeye, E. D.,Kinander, W., Tønjum, T., Bekele, S., Mannsåker, T., Bjune,G., Aseffa, A. & Holm-Hansen, C. (2015). Mycobacteriumtuberculosis Lineage 7 Strains Are Associated withProlonged Patient Delay in Seeking Treatment forPulmonary Tuberculosis in Amhara Region, Ethiopia.Journal of Clinical Microbiology, 53(4), 1301-1309. https://doi.org/10.1128/JCM.03566-14




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

TIP Rev Esp Cienc Quim Biol. 2023;26

ARTíCULOS SIMILARES

CARGANDO ...